Hawaii · 2026 Regular Session · Concurrent Resolution

HCR 134: URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

In committee Last action March 18, 2026: Referred to HLT, CPC, referral sheet 19

Plain-language summary

HCR 134 is a concurrent resolution introduced in the Hawaii House on March 16, 2026. According to its official title, it concerns: URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER. Primary sponsor: David Alcos (Republican). Most recent recorded action (March 18, 2026): Referred to HLT, CPC, referral sheet 19.

Sponsors

Primary sponsor: David Alcos (Republican).